Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-25 4:43 pm Purchase | 2021-01-15 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Sarissa Capital Management LP | 8,844,000 5.000% | 8,844,000 (New Position) | Filing History |
| 2021-01-25 4:42 pm Purchase | 2021-01-15 | 13G | Mersana Therapeutics, Inc. MRSN | Sarissa Capital Management LP | 3,770,000 5.500% | 20,000 (+0.53%) | Filing History |
| 2020-12-14 08:03 am Purchase | 2020-12-11 | 13D | Innoviva, Inc. INVA | Sarissa Capital Management LP | 6,414,000 6.330% | 617,900 (+10.66%) | Filing History |
| 2020-11-23 5:02 pm Purchase | 2020-11-22 | 13D | Iterum Therapeutics plc ITRM | Sarissa Capital Management LP | 1,286,185 30.950% | 1,286,185 (New Position) | Filing History |
| 2020-11-09 09:59 am Sale | 2020-11-05 | 13D | Ironwood Pharmaceuticals, Inc. IRWD | Sarissa Capital Management LP | 0 0.000% | -12,493,000 (Position Closed) | Filing History |